Information related to stock options under the Restated Employee Equity Incentive Plan and the Equity Plan for Non-Employee Directors is summarized as follows:


	Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term in Years		Aggregate Intrinsic Value (in thousands)
Outstanding at December 28, 2024		209,794		$	358.48
Granted		80,195			243.63
Exercised		-			-
Forfeited/ Expired		(2,820	)		262.25
Outstanding at June 28, 2025		287,169		$	327.35		5.94	$	514
Exercisable at June 28, 2025		149,301		$	348.09		3.73	$	514
Vested and expected to vest at June 28, 2025		262,662		$	333.17		5.63	$	514

Of the total options outstanding as of June 28, 2025, 40,103 shares were performance-based options for which the performance criteria had yet to be achieved.

On March 1, 2025, the Company granted options to purchase an aggregate of 76,919 shares of the Company’s Class A Common Stock to certain officers and other members of senior management. These options have a weighted average fair value and exercise price per share of $117.00 and $243.77, respectively.

On May 14, 2025, the Company granted options to purchase an aggregate of 3,276 shares of the Company’s Class A Common Stock to the Company’s non-employee Directors. All of the options vested immediately on the date of the grant. These options have a fair value and exercise price per share of $119.06 and $240.26, respectively.

Weighted average assumptions used to estimate fair values of stock options on the date of grants are as follows:


	2025
Expected Volatility	40.4%
Risk-free interest rate	4.3%
Expected Dividends	0.0%
Exercise factor		2.1
Discount for post-vesting restrictions	0.0%

Information related to vesting activities of restricted stock units and investment share program under the Restated Employee Equity Incentive Plan and restricted stock units under the Equity Plan for Non-Employee Directors is summarized as follows:


	Number of Shares			Weighted Average Fair Value
Non-vested at December 28, 2024		164,551		$	328.88
Granted		125,457			234.14
Vested		(42,120	)		358.39
Forfeited		(23,336	)		304.64
Non-vested at June 28, 2025		224,552		$	272.94

Of the total non-vested shares as of June 28, 2025, 85,209 shares were performance-based shares for which the performance criteria had yet to be achieved.

On March 1, 2025, the Company granted a combined 111,580 shares of restricted stock units to certain officers, other member of senior management and key employees. Of the restricted stock units granted, 61,182 had performance-based vesting criteria. The remainder of restricted stock units granted on March 1, 2025 vest ratably over service periods of four years. Additionally, on March 1, 2025, employees elected to purchase a combined 12,251 shares under the Company’s investment share program. The weighted average fair value of the restricted stock units and investment shares, which are sold to employees at discount under its investment share program, was $243.77 and $145.64 per share, respectively.

On May 14, 2025, the Company granted a combined 1,626 shares of restricted stock units to the Company’s non-employee Directors, of which all shares vest one year from the grant date. The fair value of the restricted stock units was $240.26 per share.

The following table provides information regarding stock-based compensation expense included in operating expenses in the accompanying condensed consolidated statements of comprehensive operations:


	Thirteen weeks ended				Twenty-six weeks ended
	June 28, 2025		June 29, 2024		June 28, 2025		June 29, 2024
	(in thousands)				(in thousands)
Amounts included in advertising, promotional and selling expenses	$	1,764	$	1,465	$	4,005	$	3,930
Amounts included in general and administrative expenses		3,290		2,416		6,919		7,078
Total stock-based compensation expense	$	5,054	$	3,881	$	10,924	$	11,008

In 1998, the Company began a share repurchase program. Under this program, the Company's Board of Directors has authorized the repurchase of the Company's Class A Stock. On October 2, 2024, the Board of Directors authorized an increase in the aggregate expenditure limit for the Company’s stock repurchase program by $400.0 million, increasing the limit from $1.2 billion to $1.6 billion. The Board of Directors did not specify a date upon which the total authorization would expire and, in the future, can further increase the authorized amount. Share repurchases under this program for the periods included herein were effected through open market transactions.

During the thirteen and twenty-six weeks ended June 28, 2025, the Company repurchased and subsequently retired 217,426 and 418,673 shares of its Class A Common Stock, respectively, for an aggregate purchase price of $49.9 million and $99.1 million, respectively. As of June 28, 2025, the Company had repurchased a cumulative total of approximately 15.3 million shares of its Class A Common Stock for an aggregate purchase price of approximately $1.27 billion and had approximately $328 million remaining on the $1.6 billion stock repurchase expenditure limit set by the Board of Directors.